Two commercially available kits, the EarlyTect-Colon Cancer and Colosafe, which respectively received approval from the Korean Food and Drug Administration and the China National Medical Products Administration, have been designed to only detect methylated Syndecan2 (SDC2) genes [85,86]. Here, SDC2 is linked to colonic neoplasm.